These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 29195005)

  • 1. Synthetic Indolactam V Analogues as Inhibitors of PAR2-Induced Calcium Mobilization in Triple-Negative Breast Cancer Cells.
    Stein J; Stahn S; Neudörfl JM; Sperlich J; Schmalz HG; Teusch N
    ChemMedChem; 2018 Jan; 13(2):147-154. PubMed ID: 29195005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling, chemistry, and biology of the benzolactam analogues of indolactam V (ILV). 2. Identification of the binding site of the benzolactams in the CRD2 activator-binding domain of PKCdelta and discovery of an ILV analogue of improved isozyme selectivity.
    Kozikowski AP; Wang S; Ma D; Yao J; Ahmad S; Glazer RI; Bogi K; Acs P; Modarres S; Lewin NE; Blumberg PM
    J Med Chem; 1997 Apr; 40(9):1316-26. PubMed ID: 9135029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of synthetic analogues of teleocidin, indolactam-V, on the differentiation of murine pre-adipose cells.
    Sato M; Hiragun A; Shudo K
    Cancer Lett; 1985 Jan; 25(3):261-9. PubMed ID: 3918784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationship in the induction of Epstein-Barr virus by teleocidin derivatives.
    Irie K; Tokuda H; Hagiwara N; Koshimizu K; Hayashi H; Murao S; Ito Y
    Int J Cancer; 1985 Oct; 36(4):485-8. PubMed ID: 2995261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modular Total Synthesis of Protein Kinase C Activator (-)-Indolactam V.
    Haynes-Smith J; Diaz I; Billingsley KL
    Org Lett; 2016 May; 18(9):2008-11. PubMed ID: 27074538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic analogues (indolactams) of (-)-indolactam-V are new congeners of the teleocidin class of tumor promoters.
    Hirota M; Suganuma M; Yoshizawa S; Horiuchi T; Nakayasu M; Hasegawa M; Endo Y; Shudo K; Fujiki H
    Jpn J Cancer Res; 1987 Jun; 78(6):577-82. PubMed ID: 3112073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Teleocidin A2 inhibits human proteinase-activated receptor 2 signaling in tumor cells.
    Stahn S; Thelen L; Albrecht IM; Bitzer J; Henkel T; Teusch NE
    Pharmacol Res Perspect; 2016 Aug; 4(4):e00230. PubMed ID: 28116092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Potent Antagonist of Protease-Activated Receptor 2 That Inhibits Multiple Signaling Functions in Human Cancer Cells.
    Jiang Y; Yau MK; Lim J; Wu KC; Xu W; Suen JY; Fairlie DP
    J Pharmacol Exp Ther; 2018 Feb; 364(2):246-257. PubMed ID: 29263243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of alteration of the heterocyclic nucleus of ILV on its isoform selectivity for PKC. Palladium catalyzed route to benzofuran analogues of ILV.
    Kozikowski AP; Ma D; Du L; Lewin NE; Bumberg PM
    Farmaco; 1995 Jun; 50(6):425-30. PubMed ID: 7669180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid-phase synthesis and biological evaluation of a teleocidin library--discovery of a selective PKCdelta down regulator.
    Meseguer B; Alonso-Díaz D; Griebenow N; Herget T; Waldmann H
    Chemistry; 2000 Nov; 6(21):3943-57. PubMed ID: 11126955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity studies of the indole alkaloid tumor promoter teleocidins.
    Irie K; Hagiwara N; Tokuda H; Koshimizu K
    Carcinogenesis; 1987 Apr; 8(4):547-52. PubMed ID: 3103947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymatic Formation of Indolactam Scaffold by C-N Bond-Forming Cytochrome P450 Oxidases in Teleocidin Biosynthesis.
    Morita I; Mori T; Abe I
    Chemistry; 2021 Feb; 27(9):2963-2972. PubMed ID: 32996659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pendolmycin, a new tumor promoter of the teleocidin A class on skin of CD-1 mice.
    Nishiwaki S; Fujiki H; Yoshizawa S; Suganuma M; Furuya-Suguri H; Okabe S; Nakayasu M; Okabe K; Muratake H; Natsume M
    Jpn J Cancer Res; 1991 Jul; 82(7):779-83. PubMed ID: 1908844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel agonists and antagonists for human protease activated receptor 2.
    Barry GD; Suen JY; Le GT; Cotterell A; Reid RC; Fairlie DP
    J Med Chem; 2010 Oct; 53(20):7428-40. PubMed ID: 20873792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.
    Morris DR; Ding Y; Ricks TK; Gullapalli A; Wolfe BL; Trejo J
    Cancer Res; 2006 Jan; 66(1):307-14. PubMed ID: 16397244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of Protease-activated receptor 2 antagonists derived from phenylalanine for the treatment of breast cancer.
    Kim T; Lee Y; Lim H; Kim Y; Cho H; Namkung W; Han G
    Bioorg Chem; 2024 Sep; 150():107496. PubMed ID: 38850590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity studies on synthetic analogues (indolactams) of the tumor promoter teleocidin.
    Fujiki H; Suganuma M; Nakayasu M; Tahira T; Endo Y; Shudo K; Sugimura T
    Gan; 1984 Oct; 75(10):866-70. PubMed ID: 6595181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of intracellular Ca2+ in the regulation of proteinase-activated receptor-2 mediated nuclear factor kappa B signalling in keratinocytes.
    Macfarlane SR; Sloss CM; Cameron P; Kanke T; McKenzie RC; Plevin R
    Br J Pharmacol; 2005 Jun; 145(4):535-44. PubMed ID: 15821758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping transmembrane residues of proteinase activated receptor 2 (PAR
    Suen JY; Adams MN; Lim J; Madala PK; Xu W; Cotterell AJ; He Y; Yau MK; Hooper JD; Fairlie DP
    Pharmacol Res; 2017 Mar; 117():328-342. PubMed ID: 27993717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indolactam and benzolactam compounds as new medicinal leads with binding selectivity for C1 domains of protein kinase C isozymes.
    Irie K; Nakagawa Y; Ohigashi H
    Curr Pharm Des; 2004; 10(12):1371-85. PubMed ID: 15134488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.